NCT06428396 · Interventional trial
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
Overall registry status Active not recruiting
Phase 2
Conditions Metastatic Breast Cancer
Delaware Valley sites
- MD Anderson Cancer Center at Cooper ( Site 0024) · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory